Ovid Therapeutics Inc at TD Cowen Healthcare Conference Transcript - Thomson StreetEvents

Ovid Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Ovid Therapeutics Inc at TD Cowen Healthcare Conference Transcript - Thomson StreetEvents
Ovid Therapeutics Inc at TD Cowen Healthcare Conference Transcript
Published Mar 03, 2025
9 pages (6103 words) — Published Mar 03, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of OVID.OQ presentation 3-Mar-25 8:10pm GMT

  
Brief Excerpt:

...Good afternoon, everyone. My name is Athena Chin. I am an associate here at TD Cowen. Thank you all for joining us this afternoon. We have Meg Alexander, President and COO of Ovid Therapeutics, providing a corporate presentation. Following that, we'll open up the floor for any questions. Meg, please take it away. Meg Alexander ...

  
Report Type:

Transcript

Source:
Company:
Ovid Therapeutics Inc
Ticker
OVID.OQ
Time
8:10pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Athena Chin - TD Cowen - Analyst : Thanks, Meg. I'll kick it off with a question on OV329. So there are different kinds of epilepsies that you could pursue for your indication. Given there's so many different mechanisms in development currently for different kinds of epilepsy, how are you going to select for the indication that you do decide to pursue later on for optimal success?


Question: Athena Chin - TD Cowen - Analyst : Why do you think the FDA is now changing their mind about basket DEE trials? I mean, Lundbeck is or Longboard is doing one and practiceis might be also pursuing one. What do you think drove that change?


Question: Athena Chin - TD Cowen - Analyst : Definitely, any questions in the audience? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. MARCH 03, 2025 / 8:10PM, OVID.OQ - Ovid Therapeutics Inc at TD Cowen Healthcare Conference Unidentified Participant Just curious, for OV329, you mentioned that it has a lack of micro addition and it has a more selective enamine condensation or its activation. Just curious on how you think that might impact the intolerability profile of the drug.


Question: Athena Chin - TD Cowen - Analyst : I have a question on KCC2. So you said that you were trying to target an indication that would be more homogeneous but still have a high unmet need. Gresh would be PDP.


Question: Athena Chin - TD Cowen - Analyst : So besides differentiating on safety, how do you think based on the pre-clinical data you have seen that it might drive a higher efficacy than what is available currently for these patients?

Table Of Contents

Ovid Therapeutics Inc Extraordinary Shareholders Meeting Transcript – 2025-12-11 – US$ 54.00 – Edited Transcript of OVID.OQ shareholder or annual meeting 11-Dec-25 2:00pm GMT

Ovid Therapeutics Inc to Discuss OV329 Phase 1 Topline Results Transcript – 2025-10-03 – US$ 54.00 – Edited Transcript of OVID.OQ conference call or presentation 3-Oct-25 12:30pm GMT

Ovid Therapeutics Inc Annual Shareholders Meeting Transcript – 2025-07-09 – US$ 54.00 – Edited Transcript of OVID.OQ shareholder or annual meeting 9-Jul-25 1:00pm GMT

Ovid Therapeutics Inc To Host Investor Event Transcript – 2025-06-12 – US$ 54.00 – Edited Transcript of OVID.OQ conference call or presentation 12-Jun-25 1:30pm GMT

Ovid Therapeutics Inc To Host KCC2 Download Day Transcript – 2024-11-13 – US$ 54.00 – Edited Transcript of OVID.OQ corporate analyst meeting</ 13-Nov-24 2:30pm GMT

Ovid Therapeutics Inc Annual Shareholders Meeting Transcript – 2024-06-06 – US$ 54.00 – Edited Transcript of OVID.OQ shareholder or annual meeting 6-Jun-24 2:00pm GMT

Ovid Therapeutics Inc To Host Research & Development (R&D) Day Transcript – 2023-10-02 – US$ 54.00 – Edited Transcript of OVID.OQ corporate analyst meeting</ 2-Oct-23 4:00pm GMT

Ovid Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript – 2023-04-17 – US$ 54.00 – Edited Transcript of OVID.OQ presentation 17-Apr-23 3:00pm GMT

Ovid Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript – 2022-04-14 – US$ 54.00 – Edited Transcript of OVID.OQ presentation 14-Apr-22 4:45pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ovid Therapeutics Inc at TD Cowen Healthcare Conference Transcript" Mar 03, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Ovid-Therapeutics-Inc-at-TD-Cowen-Healthcare-Conference-T16277239>
  
APA:
Thomson StreetEvents. (2025). Ovid Therapeutics Inc at TD Cowen Healthcare Conference Transcript Mar 03, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Ovid-Therapeutics-Inc-at-TD-Cowen-Healthcare-Conference-T16277239>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.